Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial.
Christian AlbertJanine MikolajczakAnja LiekfeldSophie K PiperMichael ScheelHanna G ZimmermannClaus NowakJan DörrJudith Bellmann-StroblClaudia ChienAlexander U BrandtFriedemann PaulOlaf HoffmannPublished in: BMC neurology (2020)
The trial was registered as EUDRA-CT 2011-004787-30 on October 26, 2012 and as NCT01647880 on July 24, 2012.
Keyphrases
- multiple sclerosis
- liver failure
- respiratory failure
- image quality
- study protocol
- phase iii
- computed tomography
- clinical trial
- dual energy
- contrast enhanced
- optical coherence tomography
- phase ii
- aortic dissection
- drug induced
- positron emission tomography
- optic nerve
- randomized controlled trial
- hepatitis b virus
- open label
- magnetic resonance
- extracorporeal membrane oxygenation